Prevention of excessive vaginal bleeding after vaginal using misoprostol - Trial PACTR201303000459148
Access comprehensive clinical trial information for PACTR201303000459148 through Pure Global AI's free database. This Not Applicable trial is sponsored by Makerere University and is currently Recruiting. The study focuses on Pregnancy and Childbirth; Other.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Makerere University
Welcome Trust (THRiVE); Makerere University
Timeline & Enrollment
Not Applicable
Feb 14, 2013
Jan 01, 1900
Summary
Post Partum Haemorrhage(PPH) remains a leading cause of maternal deaths in Africa. Effective tools(oxytocics) for prevention of PPH are available, however not practical for use in low-income countries with many home births. Uganda DHS 2011 showed that 33% of the women deliver occur at home. WHO does not recommend community distribution of misoprostol for PPH prevention.the aim is to assess the effectiveness and safety of self administered misoprostol in prevention of PPH after home births.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR201303000459148
Non-Device Trial